| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Aug 18, 2025 | Option/RSU Exercise | $70.20 | 11,250 | 789,750 | 28,054 | Aug 19, 2025, 05:26 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Aug 18, 2025 | Sale | $450.00 | 11,250 | 5,062,500 | 16,804 | Aug 19, 2025, 05:26 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | May 15, 2025 | Option/RSU Exercise | $131.21 | 11,250 | 1,476,113 | 28,054 | May 19, 2025, 04:17 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | May 15, 2025 | Sale | $277.71 | 11,250 | 3,124,217 | 27,505 | May 19, 2025, 04:17 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Dec 27, 2023 | Option/RSU Exercise | $96.45 | 30,000 | 2,893,500 | 46,029 | Dec 29, 2023, 04:03 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Dec 27, 2023 | Sale | $195.00 | 30,000 | 5,850,000 | 16,029 | Dec 29, 2023, 04:03 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Aug 02, 2023 | Option/RSU Exercise | - | 22,477 | - | 22,477 | Aug 04, 2023, 04:02 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Aug 03, 2023 | Sale | $185.38 | 6,448 | 1,195,310 | 22,177 | Aug 04, 2023, 04:02 PM | |
| BMY | BRISTOL MYERS SQUIBB CO | Michael W. Bonney | Director | Jun 13, 2021 | Option/RSU Exercise | - | 902 | - | 12,501 | Jun 14, 2021, 06:56 PM | |
| BMY | BRISTOL MYERS SQUIBB CO | Michael W. Bonney | Director | Jun 13, 2020 | Option/RSU Exercise | - | 903 | - | 8,092 | Jun 16, 2020, 05:16 PM | |
| BMY | BRISTOL MYERS SQUIBB CO | Michael W. Bonney | Director | Jun 14, 2020 | Option/RSU Exercise | - | 558 | - | 8,650 | Jun 16, 2020, 05:16 PM | |
| BMY | BRISTOL MYERS SQUIBB CO | Michael W. Bonney | Director | Dec 04, 2019 | Buy | $58.90 | 88 | 5,183 | 7,189 | Jun 09, 2020, 07:16 PM | |
| BMY | BRISTOL MYERS SQUIBB CO | Michael W. Bonney | Director | Jun 03, 2020 | Option/RSU Exercise | - | 2,949 | - | 7,189 | Jun 05, 2020, 04:40 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Michael W. Bonney | Director | Sep 09, 2019 | Buy | $86.74 | 2,000 | 173,480 | 7,051 | Sep 09, 2019, 02:18 PM | |
| MGTA | Magenta Therapeutics, Inc. | Michael W. Bonney | Director | Jun 25, 2018 | Conversion | - | 21,847 | - | 215,346 | Jun 27, 2018, 04:27 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | Mar 09, 2016 | Buy | $58.36 | 2,000 | 116,720 | 4,000 | Mar 10, 2016, 06:35 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Michael W. Bonney | Director | May 12, 2015 | Buy | $112.16 | 2,000 | 224,320 | 2,000 | May 13, 2015, 06:00 PM |